SHH:600186

Lotus Health Group Company · SHH · Consumer Defensive · CNY · FY for 2025

Figures on this page computed 2026-11-08 13:30 UTC

Last close

n/aCNY

Market data

  • 51.7xP/E

    Price / Earnings per Share (diluted)

    Source
    computed
    Taken on
    2026-11-08
    Reported in
    CNY
    • computed
    • Computed from the filing for 2025
  • 22.6%ROIC

    NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash

    Source
    computed
    Taken on
    2026-11-08
    Reported in
    CNY
    • Computed from the filing for 2025
    • Computed from the filing for 2025
    • Computed from the filing for 2025
    • Computed from the filing for 2025
    • Computed from the filing for 2025
    • Computed from the filing for 2025
  • 8.9%Net margin

    Net Income / Revenue x 100

    Source
    computed
    Taken on
    2026-11-08
    Reported in
    CNY
    • Computed from the filing for 2025
    • Computed from the filing for 2025
  • 6.1%FCF margin

    Free Cash Flow / Revenue x 100

    Source
    computed
    Taken on
    2026-11-08
    Reported in
    CNY
    • Computed from the filing for 2025
    • Computed from the filing for 2025
  • 0.56Debt/equity

    Total Debt / Shareholders' Equity

    Source
    computed
    Taken on
    2026-11-08
    Reported in
    CNY
    • Computed from the filing for 2025
    • Computed from the filing for 2025
  • n/aDividend yield

    We do not hold this figure for this company, so there is nothing to place.

    Source
    computed
    Taken on
    2026-11-08
    Reported in
    CNY
    • computed

All from 100

lens 2 of 9

Sales

195
2016-12-31 to 2025-12-31100 at the start195
Sales: 100.00 on 2016-12-31 to 195.40 on 2025-12-31, up 95%.

Profit

474
2016-12-31 to 2025-12-31100 at the start474
Profit: 100.00 on 2016-12-31 to 473.76 on 2025-12-31, up 374%.

Shares in issue

129
2016-12-31 to 2025-12-31100 at the start129
Shares in issue: 100.00 on 2016-12-31 to 128.75 on 2025-12-31, up 29%.

Sales is at 195, Profit is at 474, Shares in issue is at 129, against 100 in 2016.

Sales is at 195, Profit is at 474, Shares in issue is at 129, against 100 in 2016.

Every figure in this lens

Except where said otherwise: Computed from the filing for 2025

  • Sales, where the first year is 100195
    Source
    computed
    Statement
    income
    Fiscal year
    2025
    Reported in
    CNY
  • Profit, where the first year is 100474
    Source
    computed
    Statement
    income
    Fiscal year
    2025
    Reported in
    CNY
  • Shares in issue, where the first year is 100129
    Source
    computed
    Statement
    income
    Fiscal year
    2025
    Reported in
    CNY

Filed figures cite the filing they come from; figures marked Market data are quotes as of the date shown. Not a recommendation and not advice.

Past figures are not a forecast. Anything we modelled is labelled as ours. You can lose money on any security.